Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 198

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 198
---
 share amounts):  

        Year Ended December 31,

        2024

        2023

        2022

        Net loss attributable to Adaptive Biotechnologies Corporation
         
        $
        (159,492
        )
         
        $
        (225,250
        )
         
        $
        (200,191
        )

        Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted

        147,101,648

        144,383,294

        142,515,917

        Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic and diluted
         
        $
        (1.08
        )
         
        $
        (1.56
        )
         
        $
        (1.40
        )
       
       Given the loss position for all periods presented, basic net loss per share attributable to our common shareholders is the same as diluted net loss per share attributable to our common shareholders, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive.The following weighted-average common stock equivalents were excluded from the calculation of diluted net loss per share attributable to our common shareholders for the years ended December 31, 2024, 2023 and 2022, as they had an anti-dilutive effect: 

        Year Ended December 31,

        2024

        2023

        2022

        Stock options outstanding

        12,744,898

        13,839,067

        13,892,287

        Nonvested restricted stock units outstanding

        10,584,853

        9,630,579

        4,799,850

        Maximum nonvested market-based restricted stock units outstanding eligible to be earned

        3,497,226

        1,663,961

        410,282

        Total

        26,826,977

        25,133,607

        19,102,419

18.Retirement PlanWe maintain a salary deferral 401(k) plan (“401(k) Plan”) covering employees who have met certain eligibility requirements. Employees may defer up to 100% of their compensation to the 401(k) Plan, subject to federal limits. We made $2.0 million, $2.3 million and $2.8 million in